Northern Trust’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-583,069
Closed -$39.7M 4786
2022
Q3
$39.7M Buy
583,069
+8,647
+2% +$589K 0.01% 994
2022
Q2
$18.4M Sell
574,422
-11,975
-2% -$383K ﹤0.01% 1589
2022
Q1
$20.3M Sell
586,397
-22,881
-4% -$793K ﹤0.01% 1664
2021
Q4
$17.8M Buy
609,278
+5,115
+0.8% +$150K ﹤0.01% 1858
2021
Q3
$15.4M Sell
604,163
-30,115
-5% -$767K ﹤0.01% 1976
2021
Q2
$22.2M Buy
634,278
+336,306
+113% +$11.8M ﹤0.01% 1812
2021
Q1
$12.1M Buy
297,972
+2,329
+0.8% +$94.9K ﹤0.01% 2173
2020
Q4
$12.8M Sell
295,643
-1,932
-0.6% -$83.7K ﹤0.01% 2088
2020
Q3
$16.4M Sell
297,575
-10,274
-3% -$567K ﹤0.01% 1773
2020
Q2
$19.4M Sell
307,849
-399,107
-56% -$25.2M ﹤0.01% 1651
2020
Q1
$36.1M Buy
706,956
+9,246
+1% +$472K 0.01% 987
2019
Q4
$55.5M Sell
697,710
-22,655
-3% -$1.8M 0.01% 948
2019
Q3
$35M Buy
720,365
+65,380
+10% +$3.17M 0.01% 1238
2019
Q2
$34.5M Buy
654,985
+7,402
+1% +$389K 0.01% 1284
2019
Q1
$34.3M Buy
647,583
+35,447
+6% +$1.88M 0.01% 1275
2018
Q4
$25.1M Sell
612,136
-9,483
-2% -$389K 0.01% 1394
2018
Q3
$23.6M Buy
621,619
+18,930
+3% +$719K 0.01% 1654
2018
Q2
$27.2M Buy
602,689
+121,043
+25% +$5.47M 0.01% 1531
2018
Q1
$23.3M Buy
481,646
+37,751
+9% +$1.82M 0.01% 1573
2017
Q4
$17.5M Sell
443,895
-11,153
-2% -$439K ﹤0.01% 1818
2017
Q3
$14.1M Buy
455,048
+3,277
+0.7% +$102K ﹤0.01% 1974
2017
Q2
$12.4M Buy
451,771
+195,657
+76% +$5.35M ﹤0.01% 2029
2017
Q1
$9.44M Buy
256,114
+27,506
+12% +$1.01M ﹤0.01% 2160
2016
Q4
$3.3M Buy
228,608
+8,460
+4% +$122K ﹤0.01% 2816
2016
Q3
$5.08M Buy
220,148
+64,583
+42% +$1.49M ﹤0.01% 2507
2016
Q2
$2.58M Buy
155,565
+79,681
+105% +$1.32M ﹤0.01% 2897
2016
Q1
$1.2M Buy
75,884
+113
+0.1% +$1.79K ﹤0.01% 3195
2015
Q4
$2.45M Buy
75,771
+59,775
+374% +$1.93M ﹤0.01% 2935
2015
Q3
$674K Buy
+15,996
New +$674K ﹤0.01% 3421